INCYTE
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.
INCYTE
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1991-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.incyte.com
Total Employee:
501+
Status:
Active
Contact:
855-463-3463
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Brizzey
Brizzey is a firm of seasoned professionals, which guides and supports companies in planning, production, global distribution.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Promiliad Biopharma
Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-09 | ARIAD Pharmaceuticals - European operations | ARIAD Pharmaceuticals - European operations acquired by Incyte | 275 M USD |
| 2003-02-18 | Maxia Pharmaceuticals | Maxia Pharmaceuticals acquired by Incyte | N/A |
| 2000-12-01 | Proteome | Proteome acquired by Incyte | N/A |
| 1998-01-22 | Synteni | Synteni acquired by Incyte | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-02-14 | Agenus | Incyte investment in Post-IPO Equity - Agenus | 60 M USD |
| 2002-03-27 | Iconix Biosciences | Incyte investment in Venture Round - Iconix Biosciences | 20 M USD |
| 2001-07-26 | De Novo Pharmaceuticals | Incyte investment in Series B - De Novo Pharmaceuticals | 16.75 M GBP |
| 2000-06-26 | GeneEd | Incyte investment in Seed Round - GeneEd | 2 M USD |
Official Site Inspections
http://www.incyte.com Semrush global rank: 494.63 K Semrush visits lastest month: 101.15 K
- Host name: 20.119.8.32
- IP address: 20.119.8.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Incyte"
Incyte - Wikipedia
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North Ameri…See details»
Our Leadership - Incyte
Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and …See details»
Global Biopharmaceutical Company | Incyte.com
Since our start in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments across Oncology and Inflammation & Autoimmunity. …See details»
Incyte Highlights Commercial Growth, Clinical Progress and 2025 ...
13 hours ago Incyte Forward-Looking Statements. Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding the …See details»
Incyte Biosciences Canada | Biopharmaceutical …
Incyte Biosciences Canada 2600 Alfred Nobel, Suite 301 Ville St. Laurent, Quebec CANADA H4S 0A4 For general inquiries and to contact Incyte Canada, please contact [email protected].. To report a possible …See details»
Incyte - Leadership Team - The Org
The Leadership Team at Incyte is responsible for guiding the company's strategic direction and making high-level decisions that drive the drug discovery and development process. …See details»
Incyte Genomics, Inc. -- Company History
Statistics: Public Company Incorporated: 1991 as Incyte Pharmaceuticals, Inc. Employees: 585 Sales: $219.3 million (2001) Stock Exchanges: NASDAQ Ticker Symbol: INCY NAIC: 541710 …See details»
Incyte - Crunchbase Company Profile & Funding
Incyte may be growing as evidenced by crossing $1 billion in quarterly revenue for the first time, which is a significant financial milestone. Additionally, the company has reported solid growth in 2023 and is actively expanding its future …See details»
Company Profile for Incyte Corporation - Business Wire
Mar 15, 2019 Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to meet serious unmet medi Company Profile for Incyte Corporation March ...See details»
Compliance & Transparency | Incyte.com
Incyte is committed to keeping the lines of communication open and fostering a speak-up culture. The Compliance Helpline provides multiple options to speak up confidentially through a third party and report concerns or misconduct: ... the …See details»
A word from Incyte: Seven years of excellence as a
Oct 25, 2024 Incyte started as a team of 23 research scientists, chemists, and biologists in Wilmington, Delaware, working in immunology, which has now grown to more than 2,500 employees worldwide, including 1,000+ world-class …See details»
Incyte: A Global Biopharmaceutical Company on a Mission to …
Oct 19, 2023 A: Since starting with a small team of scientists, chemists, and biologists in Wilmington, Delaware in 2002, Incyte has grown into a global organization with a robust portfolio of oncology, inflammation, and autoimmunity treatments. In 2022, we reinvested 47% of our revenue into research and development efforts, and we’re always investing heavily in the …See details»
Incyte: A biopharmaceutical company with brains and heart
Feb 11, 2022 Incyte is a leading biopharmaceutical company that produces life-saving medications for illnesses, including myeloproliferative neoplasms (MPNs), …See details»
Biopharmaceutical Company | Solutions for Unmet Medical Needs …
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.See details»
Incyte Medical Information for Healthcare Professionals
Search for medical information about Incyte’s products Select a Product JAKAFI® (ruxolitinib) MONJUVI® (tafasitamab-cxix) NIKTIMVOâ„¢ (axatilimab-csfr) OPZELURA® (ruxolitinib) cream PEMAZYRE® (pemigatinib) ZYNYZ® (retifanlimab-dlwr) INCA033989 (mutCALR) INCA33890 (TGFβR2×PD-1) INCB057643 (BET) INCB123667 (CDK2) INCB161734 (KRAS G12D) …See details»
Global Biopharmaceutical Company | Incyte
Since our start in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments across Oncology and Inflammation & Autoimmunity. Today this passion for innovation is stronger than ever with a team of more than 2,500 employees who ...See details»
Incyte Corporation
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. For additional information on Incyte, please visit …See details»
Incyte Highlights Commercial Growth, Clinical Progress and 2025 ...
1 day ago WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) will provide an update on commercial growth, clinical progress and significant 2025 catalysts during a …See details»
Incyte Named One of Top 5 Companies on Science Magazine’s …
Oct 24, 2024 Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, …See details»
Incyte - Newsweek Rankings
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs through the discovery, development and ...See details»